drugset / Trial / NCT01264224

PAC-14028 in Healthy Male Volunteers

NCT01264224

Phase 1 Completed 60 enrolled Amorepacific Corporation
RandomizedSingle-groupTriple-blind

Summary

1. Primary Objective: * To evaluate safety and tolerability of single and multiple oral dosing of PAC-14028 in healthy male volunteers. 2. Secondary Objective: * To evaluate pharmacokinetics and pharmacodynamics of single and multiple oral dosing of PAC-14028 in healthy male volunteers.

Timeline

Start
2010-12
Primary completion
2012-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject PAC-14028 Unknown Oral

Indications

No indication recorded.